Engineering a designer immunotherapy – Science Magazine
|
Engineering a designer immunotherapy
Science Magazine Sockolosky et al. sought to harness the benefits of IL-2 for cancer immunotherapy, while avoiding the toxicity and undesirable expansion of Tregs, by engineering an orthogonal IL-2 and IL-2Rβ pair. Orthogonality, a term originally used in mathematics … |
